• Optimal 2:1 ratio of EPA to DHA in a highly bioavailable softgel
  
• Blend of pharmaceutical-grade omega-3 fish oils, with USP verified quality and consistency
  
• Free of lipid peroxides and environmental pollutants, including heavy metals, pesticides, dioxins, PCBs, and other harmful compounds.
  
• Sustainably sourced from fisheries
  
• From wild anchovy, sardine, and/or mackerel, one of nature's best sources of EPA and DHA.

Omega-3 fatty acids in fish oil improve a number of cardiovascular risk factors, including decreasing atherosclerotic burden, reducing triglyceride levels and blood pressure, and improving platelet and vascular function. Not only do these fatty acids modulate risk factors, but controlled clinical trials have shown them to be effective in preventing cardiovascular and coronary events, particularly in high-risk individuals.

EPA and DHA also support cognitive function through multiple mechanisms, as they are essential for neuronal membranes, the lower levels of which are found to be not only a marker of neurological disease but also a risk factor for cognitive impairment. EPA and DHA are essential for the resolution of inflammatory processes, providing substrates for anti-inflammatory prostaglandins, resolvins, and protectins.

Benefits have also been demonstrated for improving overall health, including a wide variety of cardiovascular, inflammatory, and autoimmune conditions, ranging from cardiac arrhythmias, eczema, and inflammatory bowel disease, to supporting pregnancy and lactation, rheumatoid arthritis, and neurodegenerative diseases. Meta-analyses of randomized trials have revealed that supplementation improved lipids and HbA1c and reduced proteinuria in diabetics, and improved insulin sensitivity in individuals with at least one symptom of a metabolic disorder.